Linerase Collagen 1x100mg
Important Notice
Regulated medical device (EU MDR 2017/745). For sale exclusively to qualified healthcare professionals.
What this purchase includes
- Original productFrom the manufacturer or an official distributor, CE marked.
- Batch and expiry documentedRecorded per unit on the delivery note and the invoice.
- Controlled storageOur own Madrid warehouse, 12 to 18 °C under 24 h control.
- Dispatch in 24 to 48 hFrom Madrid, insured and with a tracking number.
- Reachable Monday to Friday9:00 to 17:00 by WhatsApp and email. People, not forms.
Linerase® Collagen is micronised, sterile, pyrogen-free heterologous type I collagen (HTIC) of equine origin, supplied as a 100 mg lyophilised powder. Unlike biostimulators that induce collagen indirectly, it delivers the type I collagen molecule itself to the tissue, where it acts as a supporting matrix and activates the fibroblasts. It is reconstituted with saline immediately before injection.
- Type I collagen 100 mg per vial
- Origin heterologous equine
- Purity 99.96 %
- Reconstitution 5 ml NaCl 0.9 % → 20 mg/ml
- Needles 30G–32G, 4 mm
Composition and technology
- Heterologous type I collagen (HTIC): 100 mg per vial, as a micronised, sterile, pyrogen-free powder of equine origin.
- Purity: 99.96 %.
- Clinical concentration after reconstitution: 20 mg/ml.
- Mechanism: the delivered type I collagen acts as a three-dimensional scaffold in the dermal matrix and stimulates fibroblast activity, promoting the synthesis of the patient's own collagen.
The product contains neither hyaluronic acid nor anaesthetic. It is not a volumising filler: its effect is regeneration and improvement of the structural quality of the tissue.
Position within the Linerase range
| Linerase® Collagen | Heterologous type I collagen, 100 mg in powder form. Class III injectable medical device |
|---|---|
| Linerase® Hydro | Non-cross-linked hyaluronic acid at 1 % (10 mg/ml) with amino acids. Class III injectable medical device |
| Linerase® Medical White Peel | Biostimulating topical peel in a three-step set. Professional use |
| Linerase® Restoring Mask | Topical cosmetic mask, provided for in the post-session protocol |
| Linerase® Collagen Daily | Powdered food supplement, oral use |
Indications and treatment areas
Manufacturer's indication: adult patients with cutaneous atrophy, cutaneous hypotonia and reduced skin elasticity arising from congenital malformations or post-traumatic skin lesions.
Treatable areas according to the manufacturer's documentation: face, neck, décolleté and hands, with a reference dosage of 5 ml. The manufacturer also envisages intradermal application in the periocular area and the lips.
Technique and treatment protocol
- Reconstitution: dilute the 100 mg of powder with 5 ml of sterile 0.9 % sodium chloride solution. The resulting solution must be injected immediately after preparation.
- Route: intradermal; the manufacturer also envisages the subdermal route.
- Needle: 30G–32G, length 4 mm.
- Insertion angle: 30–45°.
- Depth: 1.5–2.5 mm on the face; up to 3–4 mm on the body.
- Technique: micropapules of approximately 0.1 ml per point, distributed in a grid pattern with a spacing of 2 to 3 cm over the treated area.
- Loading protocol: one session every 14 days, for 4 sessions.
- Maintenance: one session every two months.
- Aftercare: the manufacturer's protocol provides for the application of Linerase® Restoring Mask for 10 minutes after the session.
- Course: first visible results from 72 hours onwards, with maximum effect at around 2 weeks.
Technical data
| Manufacturer | CSD — Linerase brand (quality system certified to ISO 9001 and ISO 13485) |
|---|---|
| Active ingredient | Micronised heterologous type I collagen, 100 mg |
| Origin | Equine (heterologous) |
| Purity | 99.96 % |
| Pharmaceutical form | Sterile, pyrogen-free powder for reconstitution |
| Solvent | Sterile 0.9 % sodium chloride, 5 ml |
| Final concentration | 20 mg/ml |
| Presentation | 1 vial of 100 mg |
| Needles | 30G–32G, 4 mm (not included) |
| Route | Intradermal (subdermal depending on technique) |
| Classification | CE-marked class III medical device |
| Use | Qualified healthcare professionals only |
Storage and pack contents
- The pack includes: 1 vial containing 100 mg of heterologous type I collagen in powder form. The solvent and needles are not included.
- Storage: store the vial in its original packaging, protected from light and heat sources, in accordance with the instructions on the packaging and in the instructions for use.
- Reconstituted product: immediate use. Do not store or reuse the remainder.
- Do not use after the expiry date stated on the packaging.
- Sterile single-use vial.
Contraindications and warnings
Contraindications documented by the manufacturer: minors; pregnancy and breastfeeding; history of keloids or hypertrophic scars; active skin infection in the treatment area; immunosuppressed states; known hypersensitivity to collagen.
Warnings: product of heterologous animal origin — assess the patient's allergy history before treatment. The reconstituted solution must be injected immediately. Do not inject intravascularly.
Always consult the instructions for use enclosed in the packaging before application.
Medical device intended exclusively for qualified healthcare professionals. Technical information based on the manufacturer's official documentation (linerase.com — Collagen HTIC data sheet and frequently asked questions section). This data sheet does not replace the instructions for use accompanying the product.